Editorial Focus

Editorial Board

Our editorial advisory board reviews every technical article to ensure that each one exceeds our editorial standards for accuracy and relevancy.

  • Siddharth Advant, Senior Director, CMC Project Management, ImClone Systems, Branchburg, NJ, USA
  • Hazel Aranha, President GAEA Resources Inc., Northport, NY, USA
  • Milton J. Axley, Fellow, Process Biochemistry, MedImmune LLC, Gaithersburg, MD, USA
  • R. Lee Buckler, Managing Director, The Cell Therapy Group, Bellingham, WA (USA) and Vancouver, BC (Canada)
  • Michel Chartrain, Distinguished Senior Investigator, Merck and Co., Rahway, NJ, USA
  • Nancy Chew, Principal Consultant, Regulatory Affairs North America LLC, Durham, NC, USA
  • Christopher J. Dale, Consultant, Franklin, MA, USA
  • Laurel Donahue-Hjelle, Director of Cell Line Development, Invitrogen Corp., Rockville, MD, USA
  • John J. Dougherty, Regulatory Scientist, Eli Lilly & Company, Indianapolis, IN, USA
  • Don R. Durham, Principal, Durham Consulting LLC, Chapel Hill, NC, USA
  • Jim Faulkner, Director, Biopharmaceutical Development (UK), GlaxoSmithKline R&D, Beckenham, Kent, UK
  • Pete Gagnon, Chief Scientific Officer, Validated Biosystems, Inc., San Clemente, CA, USA
  • Timothy K. Hayes, Vice President, Analytical Chemistry, Quality and Regulatory Affairs, ProMetic BioTherapeutics Inc., Gaithersburg, MD, USA
  • Kenneth Hughes, President, Roker Biotechnologies, Inc., Toronto, ON, Canada
  • Susan Dana Jones, Senior Consultant, BioProcess Technology Consultants, Acton, MA, USA
  • Alois Jungbauer, Professor, Department of Biotechnology, University of Natural Resources and Applied Life Sciences, Vienna, Austria
  • Alex D. Kanarek, Senior Consultant, BioProcess Technology Consultants, Acton, MA, USA
  • Dennis M. Kraichely, Associate Director and CMC Team Leader, Johnson & Johnson, PA, USA
  • Vadim Klyushnichenko, Vice President, Drug Development, Terapio Corporation, Austin, TX, USA
  • Fred Mann, Program Manager, Downstream Process Solutions, Millipore Corporation Billerica, MA, USA
  • Adriana E. Manzi, President, Manzi & Associates, San Diego, CA, USA
  • Otto-Wilhelm Merten, Gene Therapy Program, Généthon II, Evry, France
  • Thomas J. Pritchett, Senior Consultant, Quality Services Consulting, Palm Desert, CA, USA
  • T. Shantha Raju, Assistant Director, Centocor Inc., Radnor, PA, USA
  • Nadine M. Ritter, Senior Consultant, Biologics Consulting Group, Alexandria, VA, USA
  • Sally Seaver, President, Seaver Associates LLC, Concord, MA, USA
  • Robert P. Shaw, Program Director, Millipore Corporation, Billerica, MA, USA
  • Abhinav Shukla, Associate Director of Manufacturing Sciences,
  • Bristol-Myers Squibb, Syracuse, NY, USA
  • Gail Sofer, Consultant, Sofeware Associates, Austin, TX, USA
  • Michiel Ultee, Chief Scientific Officer, Laureate Pharma, Princeton, NJ, USA
  • Scott M. Wheelwright, President, Strategic Manufacturing Worldwide
  • SMW Biotech, Saratoga, CA, USA
  • Shuichi Yamamoto, Professor, Process Design and Engineering Laboratory Graduate School of Medicine, Yamaguchi University, Tokiwadai, Japan
  • Jianguo Yang, Principal Scientist and Senior Manager, Commercial Cell Culture Development, Genzyme Corp., Framingham, MA, USA
  • Xiaoming (Jerry) Yang, Scientific Director, Process and Product